[Immunomodulators in the combined treatment of atherosclerotic patients].
Gandzha
I M
IM
Bobrik
M V
MV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D001161:Arteriosclerosis / Q000097:blood / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D013951:Thymus Hormones / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D008055:Lipids; D013951:Thymus Hormones; D007978:Levamisole; C032805:thymalin
Immunomoduliatory v kompleksnom lechenii bol'nykh aterosklerozom.